Skip to search formSkip to main contentSkip to account menu

dapoxetine

Known as: N,N-dimethyl-alpha-(2-(1-naphthalenyloxy)ethyl)benzenemethanamine, Dapoxetinum, Dapoxetina 
National Institutes of Health

Related topics

Related topics

5 relations

Broader (2)

BenzylaminesNaphthalenes

Narrower (1)

LY 210448
Priligydapoxetine hydrochloride

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2015
Review
2015
Premature ejaculation: old story, new insights.
Review
2012
Review
2012
Dapoxetine: a new option in the medical management of premature ejaculation
Premature ejaculation (PE) is a common male sexual disorder which is associated with substantial personal and interpersonal… 
Highly Cited
2012
Highly Cited
2012
On-demand tramadol hydrochloride use in premature ejaculation treatment.
Highly Cited
2010
Highly Cited
2010
ORIGINAL RESEARCH—EJACULATORY DISORDERS Treatment of Premature Ejaculation in the Asia-Pacific Region: Results from a Phase III Double-blind, Parallel-group Study of Dapoxetine
Introduction. Dapoxetine is a short-acting selective serotonin reuptake inhibitor that was recently approved for the on-demand… 
Highly Cited
2009
Highly Cited
2009
The Premature Ejaculation Profile: validation of self‐reported outcome measures for research and practice
To evaluate the reliability and validity of the Premature Ejaculation Profile (PEP), a self‐reported outcome instrument for… 
Highly Cited
2009
Highly Cited
2009
Treatment benefit of dapoxetine for premature ejaculation: results from a placebo‐controlled phase III trial
To evaluate the overall treatment benefit of dapoxetine for premature ejaculation (PE), with specific emphasis on improvements in… 
Highly Cited
2006
Highly Cited
2006
Efficacy and tolerability of dapoxetine in treatment of premature ejaculation: an integrated analysis of two double-blind, randomised controlled trials
Review
2006
Review
2006
Serotonin and premature ejaculation: from physiology to patient management.
Highly Cited
2006
Highly Cited
2006
Dapoxetine, a novel treatment for premature ejaculation, does not have pharmacokinetic interactions with phosphodiesterase-5 inhibitors
Potential pharmacokinetic interactions between dapoxetine, a serotonin transporter inhibitor developed for the treatment of… 
Highly Cited
2006
Highly Cited
2006
Pharmacokinetic and pharmacodynamic features of dapoxetine, a novel drug for ‘on‐demand’ treatment of premature ejaculation
Associate Editor 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)